Form 4: Clover Health Executive Sells Shares for Taxes

Clover Health Investments Corp. Interim CFO Joseph Clay Thornton reported a transaction involving the sale of Class A Common Stock to cover tax obligations upon restricted stock unit vesting.

Summary

• Joseph Clay Thornton, Interim CFO of Clover Health Investments, Corp., reported a transaction on May 16, 2026.
• This transaction involved the automatic withholding of 16,942 shares of Class A Common Stock to cover tax obligations.
• The tax withholding occurred due to the vesting of 6.25% of the original restricted stock units (RSUs) granted on February 16, 2024.
• The price per share for this withholding was $3.47.
• Following this transaction, Thornton beneficially owns 1,217,584 shares of Class A Common Stock.
• The remaining RSUs vest quarterly in equal 6.25% installments, with the final vesting scheduled for February 16, 2028, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, reflecting a routine compensation-related transaction rather than a significant strategic or financial event.

Positives

• Vesting of restricted stock units indicates continued employee engagement and potential for future value realization.
• The company has a structured RSU vesting schedule extending to February 2028, suggesting long-term incentive alignment.

Negatives

• A portion of executive compensation (RSUs) is being converted to cash to cover taxes, which could imply a cash flow consideration for the executive.
• The sale of shares, even for tax purposes, reduces the executive's direct equity holding.

Risks

• The continued vesting of RSUs is subject to the reporting person's continued service, implying a risk of forfeiture if employment is terminated.
• Fluctuations in the stock price could impact the value of the remaining RSUs and the tax liability upon future vesting.

Future Outlook

The remaining restricted stock units will vest quarterly in equal installments of 6.25% until February 16, 2028, provided the reporting person remains in service.

Industry Context

StockSavvy.ai notes that insider transactions, particularly Form 4 filings related to RSU vesting and tax withholding, are common in the healthcare technology sector as a standard part of executive compensation structures. These filings provide transparency into executive compensation realization and potential shifts in insider holdings.

Stakeholder Impact

• Shareholders: Increased transparency into executive compensation realization and potential minor shifts in insider share ownership.
• Employees: Reinforces the standard practice of RSU vesting and tax management within the company.
• Management: Reflects the standard process of managing equity-based compensation and associated tax liabilities.

Next Steps

• Continued quarterly vesting of remaining RSUs until February 16, 2028.
• Potential future tax withholdings upon subsequent RSU vesting events.

Key Dates

Keywords

Form 4, SEC Filing, Clover Health, CLOV, Joseph Clay Thornton, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Beneficial Ownership